BCAX
Bicara Therapeutics

76
Loading...
Loading...
News
all
press releases
Bicara Therapeutics (NASDAQ:BCAX) Raised to "Hold" at Mizuho
Mizuho upgraded shares of Bicara Therapeutics to a "hold" rating in a research report on Thursday...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Insider Selling: Bicara Therapeutics (NASDAQ:BCAX) COO Sells 12,500 Shares of Stock
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) COO Ryan Cohlhepp sold 12,500 shares of Bicara Therapeutics stock in a transaction that occurred on Monday, December 15th. The shares were...
MarketBeat·10d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) COO Ryan Cohlhepp Sells 12,500 Shares
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) COO Ryan Cohlhepp sold 12,500 shares of the firm's stock in a transaction on Monday, December 15th. The stock was sold at an average price of...
MarketBeat·10d ago
News Placeholder
Bicara Therapeutics Inc. (NASDAQ:BCAX) Given Average Recommendation of "Moderate Buy" by Brokerages
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat Ratings reports. One...
MarketBeat·16d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) Shares Down 3.3% - Time to Sell?
Bicara Therapeutics (NASDAQ:BCAX) Shares Down 3.3% - Should You Sell...
MarketBeat·27d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) CFO Ivan Hyep Sells 605 Shares
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CFO Ivan Hyep sold 605 shares of the firm's stock in a transaction dated Friday, November 21st. The shares were sold at an average price of...
MarketBeat·1mo ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) Insider David Raben Sells 5,500 Shares
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) insider David Raben sold 5,500 shares of the company's stock in a transaction on Monday, November 24th. The stock was sold at an average price...
MarketBeat·1mo ago
News Placeholder
Claire Mazumdar Sells 41,163 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CEO Claire Mazumdar sold 41,163 shares of the firm's stock in a transaction on Monday, November 24th. The shares were sold at an average price...
MarketBeat·1mo ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) COO Sells $225,625.00 in Stock
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) COO Ryan Cohlhepp sold 12,500 shares of the stock in a transaction dated Friday, November 21st. The stock was sold at an average price of...
MarketBeat·1mo ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) CFO Sells $330,097.25 in Stock
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CFO Ivan Hyep sold 17,795 shares of Bicara Therapeutics stock in a transaction dated Monday, November 24th. The shares were sold at an average...
MarketBeat·1mo ago
<
1
2
...
>

Latest BCAX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.